Irbesartan Tablet
Product Images NDC 50268-441

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 50268-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

440 15

Irbesartan Tablets USP 75 mg label showing unit dose packaging of 50 tablets (5 x 10). The label includes prescription-only status, barcode, and storage instructions. Manufactured for AvPAK, Pulaski, TN. The label notes to see package insert for full prescribing information and provides product revision dates.*

FDA Label Image

441 15

Label for Irbesartan Tablets USP 150 mg by AvPAK, showing two identical panels. Each panel indicates 50 tablets in unit dose packaging (5 x 10), with NDC 50268-441-15. The label includes storage instructions, Rx only designation, barcode, and manufacturer location in Pulaski, TN, with revision dates.*

FDA Label Image

442 15

The label for Irbesartan Tablets USP displays the 300 mg strength in unit dose packaging containing 50 tablets (5 x 10). The label includes the NDC code 50268-442-15 and notes that the product is Rx only. Storage instructions specify 20° to 25°C (68° to 77°F). The manufacturer is AvPAK, a product of AvKARE, based in Pulaski, TN. The label also contains QR codes and revision dates.*

FDA Label Image

Figure1.jpg (Figure1)

A line chart showing the cumulative event rate percentage over 60 months of follow-up for Irbesartan, Amlodipine, and placebo groups. The chart compares Irbesartan with placebo and Amlodipine, including associated p-values and hazard ratios in a legend.*

FDA Label Image

Figure.jpg (Figure)

Two scatter plot graphs showing the effect of Irbesartan dose (mg/day) on placebo-subtracted reduction in trough blood pressure measurements. The left graph depicts changes in trough Diastolic Blood Pressure (DBP) with dose, and the right graph depicts changes in trough Systolic Blood Pressure (SBP) with dose. Both graphs include fitted trend lines indicating dose-response relationships.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure diagram of irbesartan, showing its molecular framework including multiple ring systems and functional groups typical of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.